/Companies

Onspira Therapeutics

Wayne, US · Founded 2017 · Delaware corporation · 1 known investors

Find your way into Onspira Therapeutics

Sign up to see every warm intro you have to Onspira Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Onspira Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

RL
Roy LevittNamed on SEC filing
ST
Stephen TullmanNamed on SEC filing
PB
Paul BaroneNamed on SEC filing
BL
Brian LortieNamed on SEC filing
DG
Douglas GesslNamed on SEC filing

Investors · 1

Reported raises · per SEC filings

Form D private placements

$1.9M disclosed across 1 round · 2017

▶$1.9MraisedJun 2019 · 30 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Roy LevittExecutive Officer, Director
  • Stephen TullmanExecutive Officer, Director
  • Paul BaroneExecutive Officer, Director
  • Brian LortieExecutive Officer, Director
  • Douglas GesslExecutive Officer
Offering amount
$1.9M
Amount sold
$1.9M
Minimum investment
$4K
Proceeds to insiders
$30K
First sale
Jun 2017
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are Onspira Therapeutics's investors?
Onspira Therapeutics's investors include BioAdvance.
How much funding has Onspira Therapeutics raised?
Onspira Therapeutics has disclosed $1.9M raised across 1 round.
Where is Onspira Therapeutics headquartered?
Onspira Therapeutics is headquartered in Wayne, US.